EP4 receptor as a novel promising therapeutic target in colon cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EP4 receptor as a novel promising therapeutic target in colon cancer

Published:2020-12 Issue:12 Volume:216 Page:153247
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Karpisheh Vahid,Joshi Navneet^ORCID,Zekiy Angelina Olegovna,Beyzai Behzad,Hojjat-Farsangi Mohammad,Namdar Afshin,Edalati Mahdi,Jadidi-Niaragh Farhad

Funder

National Institute for Medical Research Development, NIMAD

Tabriz University of Medical Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference153 articles.

1. Colorectal cancer in Alaska native people, 2005–2009;Kelly;Gastroint. Cancer Res.,2012

2. GLOBOCAN 2000. Cancer Incidence, Mortality And Prevalence Worldwide, Version 1.0;Ferlay,2001

3. Cancer Incidence, Mortality And Prevalence Worldwide;Ferlay,2004

4. Cancer Incidence In Five Continents;PARKIN,1997

5. EUCAN: cancer incidence, mortality and prevalence in the European Union 1996;Ferlay;IARC Cancer base,1999

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EP4 receptor agonist CAY10598 upregulates ROS-dependent Hsp90 cleavage in colorectal cancer cells;Free Radical Research;2024-09-11

2. Bicentric lesion of colon cancer with postoperative fever: A case report;Oncology Letters;2024-08-13

3. Synthesis and Biological Activity of 2-Chloro-8-methoxy-5-methyl-5H-indolo [2,3-b] Quinoline for the Treatment of Colorectal Cancer by Modulating PI3K/AKT/mTOR Pathways;ACS Omega;2024-07-02

4. Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers;Pharmacology & Therapeutics;2024-04

5. Anti‐angiogenesis in colorectal cancer therapy;Cancer Science;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3